Study on OR502, a Monoclonal Antibody Targeting LILRB2, Alone and with Other Cancer Treatments | Clinical Trial

Study on OR502, a Monoclonal Antibody Targeting LILRB2, Alone and with Other Cancer Treatments | Clinical Trial | Right2Hope